|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
49,450,000 |
Market
Cap: |
1.33(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$26.1 - $47.5 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 623 |
Guru Rank Value : 3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Pacira BioSciences is a holding company. Through its subsidiaries, Co. is focused on non-opioid pain management. Co. has three commercialized non-opioid treatments: EXPAREL® (bupivacaine liposome injectable suspension), a long-acting, local analgesic approved for postsurgical pain management; ZILRETTA® (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular, corticosteroid injection indicated for the management of OA knee pain; and ioveradeg®, a handheld device for delivering immediate, long-acting, drug-free pain control using controlled doses of cold temperature to a targeted nerve.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
119,323 |
119,323 |
201,796 |
291,198 |
Total Sell Value |
$3,656,226 |
$3,656,226 |
$6,836,738 |
$12,122,941 |
Total People Sold |
1 |
1 |
15 |
17 |
Total Sell Transactions |
3 |
3 |
36 |
59 |
End Date |
2024-01-25 |
2023-10-24 |
2023-04-25 |
2022-04-25 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Pace Gary W |
Director |
|
2012-04-17 |
4 |
B |
$9.75 |
$97,500 |
D/D |
10,000 |
17,692 |
2.39 |
- |
|
Middleton Fred A |
Director |
|
2012-03-25 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,000 |
62,966 |
|
- |
|
Riker Lauren Bullaro |
Executive Director, Accounting |
|
2012-03-21 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,000 |
|
- |
|
Isaly Samuel D |
10% Owner |
|
2012-03-12 |
4 |
S |
$11.03 |
$696,107 |
I/I |
(63,100) |
2,446,000 |
|
- |
|
Isaly Samuel D |
10% Owner |
|
2012-03-09 |
4 |
S |
$11.25 |
$416,087 |
I/I |
(37,000) |
2,509,100 |
|
- |
|
Isaly Samuel D |
10% Owner |
|
2012-02-29 |
4 |
S |
$10.86 |
$32,584 |
I/I |
(3,000) |
2,546,100 |
|
- |
|
Isaly Samuel D |
10% Owner |
|
2012-02-28 |
4 |
S |
$11.12 |
$112,316 |
I/I |
(10,100) |
2,549,100 |
|
- |
|
Isaly Samuel D |
10% Owner |
|
2012-02-27 |
4 |
S |
$11.05 |
$320,369 |
I/I |
(29,000) |
2,559,200 |
|
- |
|
Evnin Luke |
Director |
|
2012-02-08 |
4 |
B |
$7.00 |
$3,749,998 |
I/I |
535,714 |
2,828,941 |
2.25 |
- |
|
Evnin Luke |
Director |
|
2012-02-08 |
4 |
A |
$0.00 |
$0 |
I/I |
2,200,247 |
2,293,227 |
|
- |
|
Greene William |
10% Owner |
|
2012-02-08 |
4 |
B |
$7.00 |
$3,749,998 |
I/I |
535,714 |
2,828,941 |
1.5 |
- |
|
Greene William |
10% Owner |
|
2012-02-08 |
4 |
A |
$0.00 |
$0 |
I/I |
2,200,247 |
2,293,227 |
|
- |
|
Gadicke Ansbert |
10% Owner |
|
2012-02-08 |
4 |
B |
$7.00 |
$3,749,998 |
I/I |
535,714 |
2,828,941 |
1.5 |
- |
|
Gadicke Ansbert |
10% Owner |
|
2012-02-08 |
4 |
A |
$0.00 |
$0 |
I/I |
2,200,247 |
2,293,227 |
|
- |
|
Isaly Samuel D |
10% Owner |
|
2012-02-03 |
4 |
S |
$10.79 |
$539,520 |
I/I |
(50,000) |
2,588,200 |
|
- |
|
Isaly Samuel D |
10% Owner |
|
2012-02-02 |
4 |
S |
$10.85 |
$252,917 |
I/I |
(23,300) |
2,638,200 |
|
- |
|
Isaly Samuel D |
10% Owner |
|
2012-02-01 |
4 |
S |
$11.01 |
$770,406 |
I/I |
(70,000) |
2,661,500 |
|
- |
|
Pace Gary W |
Director |
|
2011-11-21 |
4 |
B |
$6.50 |
$49,998 |
D/D |
7,692 |
7,692 |
2.39 |
- |
|
Middleton Fred A |
Director |
|
2011-11-21 |
4 |
B |
$6.50 |
$65,000 |
D/D |
10,000 |
10,000 |
3.92 |
- |
|
Hbm Bioventures Cayman Ltd |
10% Owner |
|
2011-11-21 |
4 |
B |
$6.50 |
$1,999,998 |
D/D |
307,692 |
3,445,289 |
2.45 |
- |
|
Wicki Andreas |
Director |
|
2011-11-21 |
4 |
B |
$6.50 |
$1,999,998 |
I/I |
307,692 |
3,445,289 |
2.1 |
- |
|
St Peter Steven |
10% Owner |
|
2011-11-21 |
4 |
B |
$6.50 |
$2,999,997 |
I/I |
461,538 |
3,290,479 |
1.5 |
- |
|
Evnin Luke |
Director |
|
2011-11-21 |
4 |
B |
$6.50 |
$2,999,997 |
I/I |
461,538 |
3,290,479 |
2.25 |
- |
|
Gadicke Ansbert |
10% Owner |
|
2011-11-21 |
4 |
B |
$6.50 |
$2,999,997 |
I/I |
461,538 |
3,290,479 |
1.5 |
- |
|
Isaly Samuel D |
10% Owner |
|
2011-10-31 |
4 |
S |
$10.53 |
$1,025,635 |
I/I |
(97,441) |
2,731,500 |
|
- |
|
257 Records found
|
|
Page 9 of 11 |
|
|